171 related articles for article (PubMed ID: 18806608)
1. TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity.
Kleiner Y; Bar-Am O; Amit T; Berdichevski A; Liani E; Maor G; Reiter I; Youdim MB; Binah O
J Cardiovasc Pharmacol; 2008 Sep; 52(3):268-77. PubMed ID: 18806608
[TBL] [Abstract][Full Text] [Related]
2. TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements.
Berdichevski A; Meiry G; Milman F; Reiter I; Sedan O; Eliyahu S; Duffy HS; Youdim MB; Binah O
J Pharmacol Exp Ther; 2010 Feb; 332(2):413-20. PubMed ID: 19915070
[TBL] [Abstract][Full Text] [Related]
3. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure.
Abassi ZA; Barac YD; Kostin S; Roguin A; Ovcharenko E; Awad H; Blank A; Bar-Am O; Amit T; Schaper J; Youdim M; Binah O
Circ Heart Fail; 2011 Jul; 4(4):463-73. PubMed ID: 21558446
[TBL] [Abstract][Full Text] [Related]
4. Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway.
Weinreb O; Amit T; Bar-Am O; Chillag-Talmor O; Youdim MB
Ann N Y Acad Sci; 2005 Aug; 1053():348-55. PubMed ID: 16179541
[TBL] [Abstract][Full Text] [Related]
5. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
Li W; Xu B; Xu J; Wu XL
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis.
Fu J; Huang H; Liu J; Pi R; Chen J; Liu P
Eur J Pharmacol; 2007 Jul; 568(1-3):213-21. PubMed ID: 17537428
[TBL] [Abstract][Full Text] [Related]
7. Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition.
Youdim MB; Bar Am O; Yogev-Falach M; Weinreb O; Maruyama W; Naoi M; Amit T
J Neurosci Res; 2005 Jan 1-15; 79(1-2):172-9. PubMed ID: 15573406
[TBL] [Abstract][Full Text] [Related]
8. Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes.
Du Y; Lou H
Eur J Pharmacol; 2008 Sep; 591(1-3):96-101. PubMed ID: 18611398
[TBL] [Abstract][Full Text] [Related]
9. The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusion.
Ertracht O; Liani E; Bachner-Hinenzon N; Bar-Am O; Frolov L; Ovcharenko E; Awad H; Blum S; Barac Y; Amit T; Adam D; Youdim M; Binah O
Br J Pharmacol; 2011 Jun; 163(4):755-69. PubMed ID: 21323905
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of cardiac gene transfer of CuZn-sod in comparison with the cardioprotector monohydroxyethylrutoside against doxorubicin-induced cardiotoxicity in cultured cells.
Abou El Hassan MA; Heijn M; Rabelink MJ; van der Vijgh WJ; Bast A; Hoeben RC
Cancer Gene Ther; 2003 Apr; 10(4):270-7. PubMed ID: 12679799
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine.
Bar-Am O; Weinreb O; Amit T; Youdim MB
FASEB J; 2005 Nov; 19(13):1899-901. PubMed ID: 16148027
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio.
Childs AC; Phaneuf SL; Dirks AJ; Phillips T; Leeuwenburgh C
Cancer Res; 2002 Aug; 62(16):4592-8. PubMed ID: 12183413
[TBL] [Abstract][Full Text] [Related]
13. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
[TBL] [Abstract][Full Text] [Related]
14. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.
Spallarossa P; Garibaldi S; Altieri P; Fabbi P; Manca V; Nasti S; Rossettin P; Ghigliotti G; Ballestrero A; Patrone F; Barsotti A; Brunelli C
J Mol Cell Cardiol; 2004 Oct; 37(4):837-46. PubMed ID: 15380674
[TBL] [Abstract][Full Text] [Related]
15. I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.
Barac YD; Bar-Am O; Liani E; Amit T; Frolov L; Ovcharenko E; Angel I; Youdim MB; Binah O
PLoS One; 2012; 7(11):e47890. PubMed ID: 23166584
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of hesperetin against doxorubicin-induced oxidative stress and DNA damage in rat.
Trivedi PP; Kushwaha S; Tripathi DN; Jena GB
Cardiovasc Toxicol; 2011 Sep; 11(3):215-25. PubMed ID: 21553131
[TBL] [Abstract][Full Text] [Related]
17. 4-Guanidino-n-butyl syringate (Leonurine, SCM 198) protects H9c2 rat ventricular cells from hypoxia-induced apoptosis.
Liu XH; Chen PF; Pan LL; Silva RD; Zhu YZ
J Cardiovasc Pharmacol; 2009 Nov; 54(5):437-44. PubMed ID: 19940642
[TBL] [Abstract][Full Text] [Related]
18. The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing.
Yogev-Falach M; Amit T; Bar-Am O; Youdim MB
FASEB J; 2003 Dec; 17(15):2325-7. PubMed ID: 14525944
[TBL] [Abstract][Full Text] [Related]
19. Changes in important apoptosis-related molecules in the endothelin-1-induced hypertrophied cardiomyocytes: effect of the pretreatment with eicosapentaenoic Acid.
Shimojo N; Jesmin S; Zaedi S; Soma M; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):932-6. PubMed ID: 16741026
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of 5-S-GAD against oxidative stress-induced apoptosis in RGC-5 cells.
Koriyama Y; Ohno M; Kimura T; Kato S
Brain Res; 2009 Nov; 1296():187-95. PubMed ID: 19686711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
